Antioxidants and prostate cancer
This article was originally published in The Tan Sheet
Supplementation of vitamins C, E and beta carotene in men is not linked to a reduced risk of prostate cancer, a study published Feb. 15 in the Journal of the National Cancer Institute concludes. Victoria Kirsh, NCI, et al., evaluated antioxidant intake from food and supplements in 29,361 men age 55-74 in the screening arm of the Prostate, Lung, Colorectal & Ovarian Cancer Screening Trial (PLCO). Participants completed food frequency questionnaires that included questions about supplements and were followed for an average of 4.2 years. "There was no statistically significant association between the risk of prostate cancer and the duration of use of supplemental vitamin E, beta carotene or vitamin C," the authors state, although there was a "slightly reduced risk" for participants who had used vitamin E for 10 years or more. However, "high-dose supplemental vitamin E intake was associated with a reduced risk of advanced prostate cancer in current and recent smokers," the researchers add...
You may also be interested in...
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.
In addition to our daily in-depth coverage of key regulatory events relating to the coronavirus pandemic, we’re bringing you selected brief insights into the impact on biopharma commercial activities.